TransMedics develops and sells organ-transplant technology, including its Organ Care System that keeps donor hearts, lungs and livers functioning outside the body for transport and assessment.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Howard Marks / Oaktree | 71 | New buy | 3,131,000 | $3,396,978 | 0.0% |
| Steve Cohen / Point72 | 76 | Added +1622% | 211,794 | $14,067,357 | 0.0% |
| Ancora | 40 | Holds (flat) | 500 | $33,210 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -48% | 29,400 | $1,952,748 | 0.0% |
| Trade date | Who | Type | Amount | |
|---|---|---|---|---|
| 2026-09-22 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
| 2026-09-22 | Trump, Donald J President | SELL | $15,001 - $50,000 | PTR |
| 2026-07-01 | Trump, Donald J President | SELL | $1,001 - $15,000 | PTR |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.